Integrated Diagnostics Holdings plc (LON:IDHC)
London · Delayed Price · Currency is GBP · Price in USD 0.5780
+0.0180 (3.21%)
Jun 17, 2026, 4:35 PM GMT
LON:IDHC Income Statement
Financials in millions EGP. Fiscal year is January - December.
Millions EGP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,345 | 7,855 | 5,720 | 4,123 | 3,605 | 5,225 | |
Revenue Growth (YoY) | 36.10% | 37.34% | 38.74% | 14.35% | -31.00% | 96.69% |
Cost of Revenue | 4,816 | 4,502 | 3,538 | 2,598 | 2,143 | 2,421 |
Gross Profit | 3,529 | 3,353 | 2,182 | 1,524 | 1,462 | 2,804 |
Selling, General & Admin | 1,227 | 1,227 | 963.56 | 722.02 | 589.43 | 533.18 |
Other Operating Expenses | 35.19 | -47.81 | -47.36 | -3.92 | -13.76 | -15.75 |
Operating Expenses | 1,307 | 1,224 | 964.51 | 769.35 | 605.58 | 542.08 |
Operating Income | 2,222 | 2,129 | 1,217 | 755 | 856.48 | 2,262 |
Interest Expense | -229.5 | -208.5 | -170.57 | -141.69 | -122.68 | -98 |
Interest & Investment Income | 222.91 | 222.91 | 144.68 | 72.78 | 95.37 | 113.18 |
Currency Exchange Gain (Loss) | -36.96 | -36.96 | 303.47 | 87.8 | 188.44 | -17.91 |
Other Non Operating Income (Expenses) | 92.73 | -27.27 | -26.32 | -19.3 | -12.91 | -20.03 |
EBT Excluding Unusual Items | 2,271 | 2,079 | 1,468 | 754.59 | 1,005 | 2,239 |
Merger & Restructuring Charges | - | - | - | - | -22.26 | - |
Impairment of Goodwill | - | - | - | -11.27 | - | - |
Gain (Loss) on Sale of Investments | -4.94 | -4.94 | -26 | - | -142.95 | - |
Gain (Loss) on Sale of Assets | 4.01 | 4.01 | -2.69 | 0.73 | -0.2 | 0.08 |
Asset Writedown | - | - | - | -6.71 | -1.83 | - |
Other Unusual Items | 40.12 | 40.12 | - | - | 16.18 | -6.98 |
Pretax Income | 2,311 | 2,119 | 1,440 | 737.36 | 853.65 | 2,232 |
Income Tax Expense | 816.89 | 816.89 | 431.22 | 268.99 | 327.06 | 739.82 |
Earnings From Continuing Operations | 1,494 | 1,302 | 1,008 | 468.36 | 526.58 | 1,493 |
Minority Interest in Earnings | -39.46 | -39.46 | 69.06 | 41.94 | 14.53 | -79.9 |
Net Income | 1,454 | 1,262 | 1,077 | 510.3 | 541.11 | 1,413 |
Net Income to Common | 1,454 | 1,262 | 1,077 | 510.3 | 541.11 | 1,413 |
Net Income Growth | 57.99% | 17.15% | 111.14% | -5.69% | -61.69% | 137.81% |
Shares Outstanding (Basic) | 581 | 581 | 594 | 600 | 600 | 600 |
Shares Outstanding (Diluted) | 581 | 581 | 594 | 600 | 600 | 600 |
Shares Change (YoY) | - | -2.07% | -1.06% | - | - | - |
EPS (Basic) | 2.50 | 2.17 | 1.82 | 0.85 | 0.90 | 2.35 |
EPS (Diluted) | 2.50 | 2.17 | 1.82 | 0.85 | 0.90 | 2.35 |
EPS Growth | 57.99% | 19.63% | 113.40% | -5.69% | -61.69% | 137.81% |
Free Cash Flow | - | 1,468 | 1,359 | 220.22 | -91.03 | 2,016 |
Free Cash Flow Per Share | - | 2.53 | 2.29 | 0.37 | -0.15 | 3.36 |
Dividend Per Share | - | 0.405 | 0.864 | - | - | 2.170 |
Dividend Growth | - | -53.08% | - | - | - | 184.23% |
Gross Margin | 42.29% | 42.69% | 38.14% | 36.98% | 40.56% | 53.67% |
Operating Margin | 26.63% | 27.11% | 21.28% | 18.31% | 23.76% | 43.29% |
Profit Margin | 17.42% | 16.07% | 18.84% | 12.38% | 15.01% | 27.04% |
Free Cash Flow Margin | - | 18.69% | 23.77% | 5.34% | -2.53% | 38.59% |
EBITDA | 2,576 | 2,472 | 1,517 | 1,014 | 1,063 | 2,414 |
EBITDA Margin | 30.86% | 31.47% | 26.52% | 24.61% | 29.50% | 46.20% |
D&A For EBITDA | 353.35 | 342.69 | 300.05 | 259.46 | 206.99 | 151.83 |
EBIT | 2,222 | 2,129 | 1,217 | 755 | 856.48 | 2,262 |
EBIT Margin | 26.63% | 27.11% | 21.28% | 18.31% | 23.76% | 43.29% |
Effective Tax Rate | 35.35% | 38.56% | 29.95% | 36.48% | 38.31% | 33.14% |
Advertising Expenses | - | 210.08 | 150.76 | 98.03 | 123.44 | 96.75 |